-+ 0.00%
-+ 0.00%
-+ 0.00%

Galderma H1 FY26 net income jumps 128.87% to USD 444 million; net sales climb 24.6% to USD 3.13 billion

PUBT·07/23/2026 05:06:31
Listen to the news
Galderma H1 FY26 net income jumps 128.87% to USD 444 million; net sales climb 24.6% to USD 3.13 billion
  • Galderma posted H1 2026 net sales of USD 3.13 billion, up 28% year on year on a reported basis.
  • IFRS net income rose to USD 444 million; IFRS operating profit climbed to USD 630 million.
  • Core EBITDA increased to USD 802 million; Core EBITDA margin widened to 25.6% from 22.7%.
  • Core EPS grew to USD 2.34, up 68.5% year on year.
  • Lifted 2026 net sales growth guidance to 19%-21% at constant currency; CEO Flemming Ørnskov cited broad-based growth and Swiss Market Index inclusion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galderma Group AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20260722555754) on July 23, 2026, and is solely responsible for the information contained therein.